We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

The Promise of In Vitro 3D Organoid Models: Meeting the ADME-Tox Testing Needs of the Pharmaceutical Industry

Article   Nov 11, 2019 | by Maureen Bunger, Product Manager ADME-Tox solutions, Lonza

 
The Promise of <i>In Vitro</i> 3D Organoid Models: Meeting the ADME-Tox Testing Needs of the Pharmaceutical Industry

Source: Sebastian Kaulitzki/Shutterstock

 
 
Advertisement
 

RELATED ARTICLES

Probing the Molecules of Life: An Interview With Dr Peter Nemes

Article

We recently interviewed Dr Peter Nemes to learn how his lab is "digging in a goldmine of discoveries" in developmental biology, what the future of MS-based analysis might hold and the challenges that come with probing the molecules of life that only exist for a matter of minutes.

READ MORE

The Coronavirus Pandemic

Article

On December 31, 2019, the first cases of a novel coronavirus were identified in Wuhan City, Hubei Province, China. Here, we curate a collection of news and content related to what has become the COVID-19 pandemic.

READ MORE

Stay Up-to-Date With COVID-19 Drug Development

Article

Researchers are working tirelessly to design new drugs and repurpose existing drugs against the novel coronavirus SARS-CoV-2.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE